2. Academic Validation
  3. Design and synthesis of dehydrocurvularin analogues as antibacterial and anti-biofilm agents

Design and synthesis of dehydrocurvularin analogues as antibacterial and anti-biofilm agents

  • Bioorg Chem. 2026 Jan:168:109289. doi: 10.1016/j.bioorg.2025.109289.
Jian-Jia Liang 1,  Fei-Yu Pang 2,  Yuan-Zhang Li 2,  Hong-Yue Ma 2,  Na Peng 3,  Lu Ran 1,  Ai-Yang Liu 1,  Li-Li Zou 4,  Zhang-Shuang Deng 5
Affiliations

Affiliations

  • 1 Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang 443002, China; Yichang Municipal Key Laboratory for High-Value Utilization of Citrus, Yichang 443002, China.
  • 2 Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang 443002, China.
  • 3 Key Laboratory of Tumor Microenvironment and Immunotherapy & Yichang Key Laboratory of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang 443002, Hubei, China.
  • 4 Key Laboratory of Tumor Microenvironment and Immunotherapy & Yichang Key Laboratory of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang 443002, Hubei, China. Electronic address: zoulili@ctgu.edu.cn.
  • 5 Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang 443002, China; Yichang Municipal Key Laboratory for High-Value Utilization of Citrus, Yichang 443002, China. Electronic address: dzs163@163.com.
PMID: 41325687 DOI: 10.1016/j.bioorg.2025.109289
Abstract

Developing highly effective Antibacterial agents for treating methicillin-resistant Staphylococcus aureus (MRSA) infections, especially those linked to biofilms, remains a tough problem. Here, we rationally designed and synthesized 30 novel derivatives derived from 10, 11-dehydrocurvularin through biomimetic structural modulation. Compound A25 was chosen as a candidate based on structure-activity relationship analyses against S. aureus and four clinical MRSA isolates (MIC = 2-4 μg/mL), exhibiting minimal resistance development, quickly killed bacteria, and low hemolytic activity (HC50 > 200 μg/mL). Mechanistic investigations demonstrated that A25 selectively targets Bacterial membranes by binding phosphatidylethanolamine (PE), thereby disrupting membrane polarization, elevating intracellular ROS levels, and ultimately killing bacteria. Furthermore, compound A25 showed significant anti-biofilm activity against S. aureus, highlighting its potential as a highly promising novel therapeutic candidate for combating MRSA infections.

Keywords

Antibacterial activity; Methicillin-resistant Staphylococcus aureus; Natural products; ROS.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z